Positron emission tomography imaging for gastroesophageal junction tumors Journal Article


Authors: Wu, A. J.; Goodman, K. A.
Article Title: Positron emission tomography imaging for gastroesophageal junction tumors
Abstract: Positron emission tomography (PET) is now widely used in the initial evaluation of esophageal and gastroesophageal junction tumors. It can detect otherwise occult metastases, affecting staging and treatment in a significant proportion of patients. The intensity of PET uptake before treatment has been correlated with outcomes, but it remains uncertain whether PET is an independent prognostic factor for survival. An emerging application for PET is the assessment of response to induction chemotherapy or chemoradiotherapy. In particular, PET has the ability to discriminate treatment responders from nonresponders early in the course of induction chemotherapy. This can form the basis for further treatment decisions, such as a change in chemotherapy or the addition of concurrent radiotherapy, and this approach is now being tested in prospective trials. PET after concurrent chemoradiotherapy may also provide information regarding the utility of surgical resection. PET data can affect radiotherapy target definition, which may lead to improved tumor coverage in cases where the true extent of disease is not accurately reflected by computed tomography or endoscopic imaging. © 2013 Elsevier Inc.
Journal Title: Seminars in Radiation Oncology
Volume: 23
Issue: 1
ISSN: 1053-4296
Publisher: Elsevier Inc.  
Date Published: 2013-01-01
Start Page: 10
End Page: 15
Language: English
DOI: 10.1016/j.semradonc.2012.09.001
PROVIDER: scopus
PUBMED: 23207042
DOI/URL:
Notes: --- - "Export Date: 1 April 2013" - "CODEN: SRONE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Karyn A Goodman
    257 Goodman
  2. Abraham Jing-Ching Wu
    401 Wu